Spondyloarthritis & psoriatic arthritis

Sacroiliitis in inflammatory bowel disease on abdominal computed tomography: prevalence, misses, and associated factors

Scand J RheumatolPublished Retrospective cohort study

Authors' conclusion

Physicians should carefully evaluate SI joints on abdominal CT in patients with IBD to enable early detection of sacroiliitis, potentially leading to an early diagnosis of axSpA.

Study context

Population
Patients with inflammatory bowel disease (IBD) (mean age 31.1 years) who underwent abdominal computed tomography (CT)
Participants
210 patients
Exposure
IBD patients with sacroiliitis vs without sacroiliitis
  • With sacroiliitisn = 26
Outcome
Prevalence and missed-diagnosis rate of sacroiliitis on abdominal CT
Methodological detailsvalidated abdominal CT scoring tool, univariate and multivariate regression
  • Validated abdominal CT scoring tool
  • Univariate and multivariate regression

Main finding

As reported in the abstract

Sacroiliitis on abdominal CT

Prevalence of sacroiliitis: 26 of 210

12.4%

Recognized on primary reading: 5 of 26

19.2%

Missed on initial report: 21 of 26

80.8%

Observational data: associations, not effects.

Further findings

OutcomeP value
Factors associated with sacroiliitisWith sacroiliitis vs Without sacroiliitisP = 0.04
Factors associated with sacroiliitisWith sacroiliitis vs Without sacroiliitisP = 0.04
Factors associated with sacroiliitisWith sacroiliitis vs Without sacroiliitisP < 0.01
Factors associated with sacroiliitisWith sacroiliitis vs Without sacroiliitis · multivariate analysisP = 0.01

Final axial spondyloarthritis (axSpA) diagnosis among missed cases

Diagnosed with axSpA: 20 of 21
95.2%

Original publication

Sacroiliitis in inflammatory bowel disease on abdominal computed tomography: prevalence, misses, and associated factors. Scand J Rheumatol. Published 30 April 2024. doi:10.1080/03009742.2024.2337453

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.